Back to Agenda
Concurrent Session C: Application of Pharmacogenetics in Personalized Medicine
Session Chair(s)
Hugo Alberto Barrera Saldaña, MD
Secretario Ciencia y Tecnología / CEO
FM-UANL / Vitaxentrum, Mexico
Drug efficacy and adverse drug reactions are usually dose-dependent and determine the clinical outcome of the administration of a particular drug. Personalized Medicine focuses on matching type and dosage according to individual genetic variation. This session will discuss the application of pharmacogenetics for volunteer selection on new drugs and bioequivalence clinical trials. In the case of bioequivalence studies, volunteer selection based on a specifi c metabolism type (fast, normal or slow) could provide more accurate trial results and clinical outcomes. The application of pharmacogenetics in Clinical Trials will be discussed.
Speaker(s)
Mexican Population, Clinical Significance for Anticoagulants
Vanessa Gonzalez, MD
INMEGEN, Mexico
Associate Researcher
Application of Pharmacogenetics in Personal Medicine
Xavier Soberon, MD
INMEGEN, Mexico
Director
Pharmacogenetics of Pharmacokinetics Highly Variable Drugs
Rafael Baltazar Reyes Lyon, MD
Universidad de Monterrey, Mexico
Professor
Have an account?